89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Authors
Keywords
<sup>89</sup>Zr-huJ591, J591 antibody, Prostate cancer, Radioimmunotherapy, Dosimetry
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 41, Issue 11, Pages 2093-2105
Publisher
Springer Nature
Online
2014-08-20
DOI
10.1007/s00259-014-2830-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new 68Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging
- (2014) Donghui Pan et al. AMINO ACIDS
- Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
- (2014) Christian M. Zechmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
- (2014) Gesche Wieser et al. Theranostics
- 18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients
- (2013) Cristina Nanni et al. Clinical Genitourinary Cancer
- 11C-Choline PET/CT Scan in Patients With Prostate Cancer Treated With Intermittent ADT
- (2013) Francesco Ceci et al. CLINICAL NUCLEAR MEDICINE
- 11C-Choline PET/CT and PSA kinetics
- (2013) Paolo Castellucci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PSMA as a target for radiolabelled small molecules
- (2013) Matthias Eder et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction
- (2013) M. Haseebuddin et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
- (2013) J. A. Barrett et al. JOURNAL OF NUCLEAR MEDICINE
- Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial
- (2013) David M. Schuster et al. JOURNAL OF UROLOGY
- Preclinical Evaluation of a Novel 111In-Labeled Bombesin Homodimer for Improved Imaging of GRPR-Positive Prostate Cancer
- (2013) G. Carlucci et al. MOLECULAR PHARMACEUTICS
- Localized Prostate Cancer Detection with18F FACBC PET/CT: Comparison with MR Imaging and Histopathologic Analysis
- (2013) Baris Turkbey et al. RADIOLOGY
- Monitoring the Clinical Outcomes in Advanced Prostate Cancer: What Imaging Modalities and Other Markers Are Reliable?
- (2013) Michael J. Morris et al. SEMINARS IN ONCOLOGY
- Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer
- (2012) Zilin Yu et al. AMINO ACIDS
- 11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
- (2012) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog
- (2012) I. Dijkgraaf et al. JOURNAL OF NUCLEAR MEDICINE
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- (2012) S. Y. Cho et al. JOURNAL OF NUCLEAR MEDICINE
- Bombesin analogues for gastrin-releasing peptide receptor imaging
- (2012) Prasant K. Nanda et al. NUCLEAR MEDICINE AND BIOLOGY
- Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
- (2011) Rogier P. J. Schroeder et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy
- (2011) S. M. Hillier et al. JOURNAL OF NUCLEAR MEDICINE
- Bombesin Antagonist-Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors
- (2011) K. Abiraj et al. JOURNAL OF NUCLEAR MEDICINE
- Prospects in radionuclide imaging of prostate cancer
- (2011) Susanne Lütje et al. PROSTATE
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
- (2010) J. P. Holland et al. JOURNAL OF NUCLEAR MEDICINE
- Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
- (2010) Maria J W D Vosjan et al. Nature Protocols
- Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
- (2009) Michael C. Haffner et al. HUMAN PATHOLOGY
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using 111In-J591: Lesion Detectability and Dosimetric Projections for 90Y Radioimmunotherapy
- (2008) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now